Kara M A, Peters F P, Rosmolen W D, Krishnadath K K, ten Kate F J, Fockens P, Bergman J J G H
Dept. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Endoscopy. 2005 Oct;37(10):929-36. doi: 10.1055/s-2005-870433.
High-resolution endoscopy (HRE) may improve the detection of early neoplasia in Barrett's esophagus. Indigo carmine chromoendoscopy (ICC) and narrow-band imaging (NBI) may be useful techniques to complement HRE. The aim of this study was to compare HRE-ICC with HRE-NBI for the detection of high-grade dysplasia or early cancer (HGD/EC) in patients with Barrett's esophagus.
Twenty-eight patients with Barrett's esophagus underwent HRE-ICC and HRE-NBI (separated by 6 - 8 weeks) in a randomized sequence. The two procedures were performed by two different endoscopists, who were blinded to the findings of the other examination. Targeted biopsies were taken from all detected lesions, followed by four-quadrant biopsies at 2-cm intervals. Biopsy evaluation was supervised by a single expert pathologist, who was blinded to the imaging technique used.
Fourteen patients were diagnosed with HGD/EC. The sensitivity for HGD/EC was 93 % and 86 % for HRE-ICC and HRE-NBI, respectively. Targeted biopsies had a sensitivity of 79 % with HRE alone. HGD was diagnosed from random biopsies alone in only one patient. ICC and NBI detected a limited number of additional lesions occult to HRE, but these lesions did not alter the sensitivity for identifying patients with HGD/EC.
In most patients with high-grade dysplasia or early cancer in Barrett's esophagus, subtle lesions can be identified with high-resolution endoscopy. Indigo carmine chromoendoscopy and narrow-band imaging are comparable as adjuncts to high-resolution endoscopy.
高分辨率内镜检查(HRE)可能会提高巴雷特食管早期瘤变的检出率。靛胭脂染色内镜检查(ICC)和窄带成像(NBI)可能是补充HRE的有用技术。本研究的目的是比较HRE-ICC与HRE-NBI在巴雷特食管患者中检测高级别异型增生或早期癌症(HGD/EC)的效果。
28例巴雷特食管患者按随机顺序接受了HRE-ICC和HRE-NBI检查(间隔6 - 8周)。这两种检查由两名不同的内镜医师进行,他们对另一种检查的结果不知情。对所有检测到的病变进行靶向活检,然后每隔2厘米进行四象限活检。活检评估由一名独立的专家病理学家监督,他对所使用的成像技术不知情。
14例患者被诊断为HGD/EC。HRE-ICC和HRE-NBI对HGD/EC的敏感度分别为93%和86%。仅HRE时靶向活检的敏感度为79%。仅通过随机活检诊断出HGD的患者只有1例。ICC和NBI检测到了少量HRE未发现的额外病变,但这些病变并未改变识别HGD/EC患者的敏感度。
在大多数巴雷特食管高级别异型增生或早期癌症患者中,高分辨率内镜检查可以识别细微病变。靛胭脂染色内镜检查和窄带成像作为高分辨率内镜检查的辅助手段效果相当。